In ₹ Crore except Per Share Latest Annual	SARVESHWAR FY26	SUKHJITS FY26	NATHBIOGEN FY26	INDOUS FY26	Peer Average
Valuation — at last close
P/E	12.24×	25.20×	◆ 6.31×	11.98×	14.50× -16%
P/B	0.92×	0.78×	◆ 0.37×	1.70×	0.95× -3%
EV/EBITDA	10.34×	8.29×	◆ 5.99×	11.05×	8.45× +22%
Market Cap	₹437 Cr	₹445 Cr	₹252 Cr	₹157 Cr	₹284 Cr +54%
Growth
Revenue CAGR 3Y	◆ 24.98%	-0.33%	13.88%	—	6.78% +269%
Net Income CAGR 3Y	◆ 59.78%	-24.72%	5.93%	—	-9.39% +736%
Revenue YoY (latest Q)	18.81%	◆ 29.71%	15.76%	-51.22%	-1.92% +1081%
Net Income YoY (latest Q)	17.04%	◆ 255.12%	-13.46%	-206.35%	11.77% +45%
Profitability
EBITDA Margin	4.91%	5.77%	11.78%	◆ 15.40%	10.98% -55%
Net Income Margin	2.36%	1.89%	9.35%	◆ 11.88%	7.71% -69%
Return on Common Equity	8.13%	4.87%	6.28%	◆ 15.34%	8.83% -8%
Return on Capital Employed	16.11%	6.48%	7.11%	◆ 18.40%	10.66% +51%
Return on Assets	3.19%	2.55%	3.92%	◆ 11.36%	5.94% -46%
Credit & Quality
Total Debt/Equity	0.52×	0.58×	◆ 0.20×	0.40×	0.39× +32%
Interest Coverage	2.44×	1.54×	3.03×	◆ 7.18×	3.92× -38%
Scale — latest FY
Revenue / Total Income	₹1,346 Cr	₹1,432 Cr	₹445 Cr	₹110 Cr	₹663 Cr +103%
Net Income	₹31.8 Cr	₹27 Cr	₹41.6 Cr	₹13.1 Cr	₹27.3 Cr +17%
Total Assets	₹1,089 Cr	₹1,089 Cr	₹1,097 Cr	₹133 Cr	₹773 Cr +41%
EPS	₹0.29	₹5.65	₹20.98	₹6.54	₹11.06 -97%
Book Value per Share	₹3.87	₹181.61	₹358.06	₹46.15	₹195.27 -98%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.